Aballi John
Exagen Inc. · President and CEO
Aballi John is listed in public filings as director, officer: President and CEO. This Aballi John insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Exagen Inc. (XGN). Investors use Aballi John's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $553k175k shares | Grant / ExerciseMar 12, 2026 | $316.0K100k shares | $3.16 | -- | |
| --839.8k shares | Grant / ExerciseMar 12, 2026 | Disclosure amount unavailable150k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.5M687.3k shares | SellMar 3, 2026 | $56.8K15.7k shares | $3.62 | -- | |
| $2.1M689.8k shares | Grant / ExerciseMar 3, 2026 | $7.8K2.5k shares | $3.08 | -- | |
| $2.5M703k shares | SellFeb 24, 2026 | $41.3K11.4k shares | $3.61 | -- | |
| $8.4M714.4k shares | SellOct 16, 2025 | $375.6K31.8k shares | $11.82 | -- | |
| $1.8M746.2k shares | Grant / ExerciseFeb 28, 2025 | $21.3K8.6k shares | $2.47 | -- | |
| $269k75k shares | Grant / ExerciseFeb 21, 2025 | $268.5K75k shares | $3.58 | -- | |
| --737.6k shares | Grant / ExerciseFeb 21, 2025 | Disclosure amount unavailable112.5k shares | -- | -- | |
| $1.9M689.8k shares | BuyNov 14, 2024 | $68.3K24.3k shares | $2.81 | -- |